HSDT · Insider Trading
Solana Company Class A Common Stock (DE)
Every open-market purchase and sale reported by HSDT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Agustina Gani Tjandrasuwita | See Remarks | A | +88,817 deriv. | — |
| 2026-08-04 | Choon Wee Chee | CEO and President | A | +923,000 deriv. | — |
| 2026-07-13 | Summer Wisdom Holdings Ltd | 10%+ Owner | J | −1,453,277 | — |
| 2026-06-04 | Cosmo Yi Jiang | Director | A | +1,005,040 deriv. | — |
| 2026-06-04 | Cosmo Yi Jiang | Director | MIXED | +1,004,430 | −$1 |
| 2026-05-26 | Sergio Mello | Director | A | +6,360 | — |
| 2026-05-26 | Blane Walter | Director | A | +2,180 | — |
| 2026-05-26 | Edward M Straw | Director | A | +2,180 | — |
| 2026-05-26 | Blane Walter | Director | A | +6,360 | — |
| 2026-05-26 | Edward M Straw | Director | A | +6,360 | — |
| 2026-05-26 | Michel Kai Tai Lee | Director | A | +6,360 | — |
| 2026-05-22 | Fusion Summer Ltd | 10%+ Owner | J | −1,453,277 | — |
| 2026-05-13 | Choon Wee Chee | Executive Chairman | M | +1,109,118 | — |
| 2026-04-02 | Blane Walter | Director | A | +2,180 | — |
| 2026-04-02 | Paul Buckman | Director | A | +2,180 | — |
| 2026-04-02 | Sherrie L Perkins | Director | A | +2,180 | — |
| 2026-04-02 | Edward M Straw | Director | A | +2,180 | — |
| 2025-07-03 | Sherrie L Perkins | Director | A | +2,600 deriv. | — |
| 2025-07-03 | Paul Buckman | Director | A | +2,600 deriv. | — |
| 2025-07-03 | Pelt Antonella R. Favit-Van | Chief Medical Officer | A | +17,500 deriv. | — |
| 2025-07-03 | Dane Andreeff | President and CEO | A | +52,400 deriv. | — |
| 2025-07-03 | Jeffrey S Mathiesen | CFO and Treasurer | A | +26,200 deriv. | — |
| 2025-07-03 | Edward M Straw | Director | A | +2,600 deriv. | — |
| 2025-07-03 | Blane Walter | Director | A | +2,600 deriv. | — |
| 2025-01-08 | Edward M Straw | Director | A | +10,732 deriv. | — |
| 2025-01-08 | Jeffrey S Mathiesen | CFO and Treasurer | A | +139,857 deriv. | — |
| 2025-01-08 | Paul Buckman | Director | A | +10,732 deriv. | — |
| 2025-01-08 | Pelt Antonella R. Favit-Van | Chief Medical Officer | A | +95,892 deriv. | — |
| 2025-01-08 | Dane Andreeff | President and CEO | A | +279,715 deriv. | — |
| 2025-01-08 | Blane Walter | Director | A | +10,732 deriv. | — |
| 2025-01-08 | Sherrie L Perkins | Director | A | +10,732 deriv. | — |
| 2024-07-05 | Blane Walter | Director | A | +31,000 deriv. | — |
| 2024-07-05 | Edward M Straw | Director | A | +31,000 deriv. | — |
| 2024-07-05 | Sherrie L Perkins | Director | A | +31,000 deriv. | — |
| 2024-07-05 | Pelt Antonella R. Favit-Van | Chief Medical Officer | A | +277,000 deriv. | — |
| 2024-07-05 | Paul Buckman | Director | A | +31,000 deriv. | — |
| 2024-07-05 | Dane Andreeff | President and CEO | A | +808,000 deriv. | — |
| 2024-07-05 | Jeffrey S Mathiesen | CFO and Treasurer | A | +404,000 deriv. | — |
| 2024-02-15 | Dane Andreeff | President and CEO | Buy | +1,284 | +$8.23K |
| 2023-12-15 | Dane Andreeff | President and CEO | Buy | +5,000 | +$40.48K |
| 2023-12-04 | Dane Andreeff | President and CEO | Buy | +4,006 | +$25.68K |
| 2023-08-30 | Dane Andreeff | President and CEO | Buy | +10,078 | +$70.55K |
| 2023-05-26 | Blane Walter | Director | A | +83,054 | — |
| 2023-05-26 | Sherrie L Perkins | Director | A | +83,054 | — |
| 2023-05-26 | Edward M Straw | Director | A | +83,054 | — |
| 2023-05-26 | Paul Buckman | Director | A | +83,054 | — |
| 2023-02-16 | Jeffrey S Mathiesen | CFO and Treasurer | A | +2,693,000 deriv. | — |
| 2023-02-16 | Pelt Antonella R. Favit-Van | Chief Medical Officer | A | +1,463,000 deriv. | — |
| 2023-02-16 | Dane Andreeff | President and CEO | A | +5,181,000 deriv. | — |
| 2022-12-19 | Dane Andreeff | President and CEO | Buy | +80,041 | +$19.95K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Choon Wee Chee | CEO and President | 6,486,243 | $11.22M |
| Fusion Summer Ltd | 10%+ Owner | 5,377,125 | $9.30M |
| Summer Wisdom Holdings Ltd | 10%+ Owner | 5,377,125 | $9.30M |
| Cosmo Yi Jiang | Director | 1,004,430 | $1.74M |
| Sherrie L Perkins | Director | 92,220 | $159.54K |
| Paul Buckman | Director | 92,004 | $159.17K |
| Edward M Straw | Director | 8,542 | $14.78K |
| Blane Walter | Director | 8,542 | $14.78K |
| Michel Kai Tai Lee | Director | 6,360 | $11.00K |
| Sergio Mello | Director | 6,360 | $11.00K |
| Dane Andreeff | President and CEO | 3 | $5 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HSDT quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.